Atlas Trials

Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome

Clinical trial NCT03197662 · COMPLETED

Trial details

NCT number
NCT03197662
Sponsor
Eric Hollander
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prader-Willi SyndromeHyperphagia
Start date
2018-04-11
Primary completion
2022-08-29
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.